To understand the synergistic anti-tumor effects induced by the deletion of ERO1A in tumors, we compared the transcriptomes of identified tumor clusters from Ero1aWT and Ero1aKO tumors based on scRNA-seq analyses (Figure 3A). This evidence concerns the gene ERO1A and neoplasm.